Sartorius Aktiengesellschaft Stock Performance
SARTF Stock | USD 182.98 9.77 5.07% |
The entity has a beta of -0.53, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Sartorius Aktiengesellscha are expected to decrease at a much lower rate. During the bear market, Sartorius Aktiengesellscha is likely to outperform the market. At this point, Sartorius Aktiengesellscha has a negative expected return of -0.21%. Please make sure to validate Sartorius Aktiengesellscha's total risk alpha and rate of daily change , to decide if Sartorius Aktiengesellscha performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Sartorius Aktiengesellschaft has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders. ...more
Begin Period Cash Flow | 203.4 M | |
Total Cashflows From Investing Activities | -569.6 M |
Sartorius |
Sartorius Aktiengesellscha Relative Risk vs. Return Landscape
If you would invest 21,224 in Sartorius Aktiengesellschaft on September 26, 2024 and sell it today you would lose (2,926) from holding Sartorius Aktiengesellschaft or give up 13.79% of portfolio value over 90 days. Sartorius Aktiengesellschaft is currently producing negative expected returns and takes up 2.26% volatility of returns over 90 trading days. Put another way, 20% of traded pink sheets are less volatile than Sartorius, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
Risk |
Sartorius Aktiengesellscha Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Sartorius Aktiengesellscha's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Sartorius Aktiengesellschaft, and traders can use it to determine the average amount a Sartorius Aktiengesellscha's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0913
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | SARTF |
Estimated Market Risk
2.26 actual daily | 20 80% of assets are more volatile |
Expected Return
-0.21 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.09 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Sartorius Aktiengesellscha is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Sartorius Aktiengesellscha by adding Sartorius Aktiengesellscha to a well-diversified portfolio.
Sartorius Aktiengesellscha Fundamentals Growth
Sartorius Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Sartorius Aktiengesellscha, and Sartorius Aktiengesellscha fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Sartorius Pink Sheet performance.
Return On Equity | 0.34 | |||
Return On Asset | 0.11 | |||
Profit Margin | 0.13 % | |||
Operating Margin | 0.27 % | |||
Current Valuation | 27.76 B | |||
Shares Outstanding | 34.23 M | |||
Price To Earning | 58.19 X | |||
Price To Book | 11.12 X | |||
Price To Sales | 6.33 X | |||
Revenue | 3.45 B | |||
EBITDA | 926.52 M | |||
Cash And Equivalents | 264.2 M | |||
Cash Per Share | 3.86 X | |||
Total Debt | 1.65 B | |||
Debt To Equity | 1.03 % | |||
Book Value Per Share | 27.44 X | |||
Cash Flow From Operations | 865.81 M | |||
Earnings Per Share | 8.43 X | |||
Total Asset | 5.7 B | |||
Current Asset | 588 M | |||
Current Liabilities | 306 M | |||
About Sartorius Aktiengesellscha Performance
By analyzing Sartorius Aktiengesellscha's fundamental ratios, stakeholders can gain valuable insights into Sartorius Aktiengesellscha's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Sartorius Aktiengesellscha has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Sartorius Aktiengesellscha has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services worldwide. The company was founded in 1870 and is headquartered in Gttingen, Germany. Sartorius operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 13832 people.Things to note about Sartorius Aktiengesellscha performance evaluation
Checking the ongoing alerts about Sartorius Aktiengesellscha for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Sartorius Aktiengesellscha help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Sartorius Aktiengesellscha generated a negative expected return over the last 90 days | |
Sartorius Aktiengesellschaft has accumulated 1.65 B in total debt with debt to equity ratio (D/E) of 1.03, which is about average as compared to similar companies. Sartorius Aktiengesellscha has a current ratio of 0.94, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Sartorius Aktiengesellscha until it has trouble settling it off, either with new capital or with free cash flow. So, Sartorius Aktiengesellscha's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Sartorius Aktiengesellscha sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Sartorius to invest in growth at high rates of return. When we think about Sartorius Aktiengesellscha's use of debt, we should always consider it together with cash and equity. | |
About 85.0% of Sartorius Aktiengesellscha outstanding shares are owned by corporate insiders | |
Latest headline from finance.yahoo.com: 18.97 Bn Mechanical Ventilator Market Opportunities and Strategies to 2033 with GE HealthCare, Getinge, Dragerwerk, ResMed, and ZOLL Medical Dominating |
- Analyzing Sartorius Aktiengesellscha's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Sartorius Aktiengesellscha's stock is overvalued or undervalued compared to its peers.
- Examining Sartorius Aktiengesellscha's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Sartorius Aktiengesellscha's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Sartorius Aktiengesellscha's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Sartorius Aktiengesellscha's pink sheet. These opinions can provide insight into Sartorius Aktiengesellscha's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Sartorius Pink Sheet analysis
When running Sartorius Aktiengesellscha's price analysis, check to measure Sartorius Aktiengesellscha's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sartorius Aktiengesellscha is operating at the current time. Most of Sartorius Aktiengesellscha's value examination focuses on studying past and present price action to predict the probability of Sartorius Aktiengesellscha's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sartorius Aktiengesellscha's price. Additionally, you may evaluate how the addition of Sartorius Aktiengesellscha to your portfolios can decrease your overall portfolio volatility.
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |